Addressing corticosteroid insensitivity in adults with asthma

Thomson, N. C. (2016) Addressing corticosteroid insensitivity in adults with asthma. Expert Review of Respiratory Medicine, 10(2), pp. 137-156. (doi: 10.1586/17476348.2016.1133304) (PMID:26678267)

120917.pdf - Accepted Version



Corticosteroids are the most effective treatment for asthma, but the therapeutic response varies markedly between individuals, with up to one third of patients showing evidence of insensitivity to corticosteroids. This article summarizes information on genetic, environmental and asthma-related factors as well as demographic and pharmacokinetic variables associated with corticosteroid insensitivity in asthma. Molecular mechanisms proposed to explain corticosteroid insensitivity are reviewed including alterations in glucocorticoid receptor subtype, binding and nuclear translocation, increased proinflammatory transcription factors and defective histone acetylation. Current therapies and future interventions that may restore corticosteroid sensitivity in asthma are discussed, including small molecule drugs and biological agents. In the future, biomarkers may be used in the clinic to predict corticosteroid sensitivity in patients with poorly controlled asthma.

Item Type:Articles
Glasgow Author(s) Enlighten ID:Thomson, Professor Neil
Authors: Thomson, N. C.
College/School:College of Medical Veterinary and Life Sciences > School of Infection & Immunity
Journal Name:Expert Review of Respiratory Medicine
Publisher:Taylor and Francis
ISSN (Online):1747-6356
Published Online:17 December 2015
Copyright Holders:Copyright © 2015 Taylor and Francis
First Published:First published in Expert Review of Respiratory Medicine 10(2):137-156
Publisher Policy:Reproduced in accordance with the copyright policy of the publisher

University Staff: Request a correction | Enlighten Editors: Update this record